Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Kian Behbakht

Concepts (439)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
40
2024
388
5.350
Why?
Poly(ADP-ribose) Polymerase Inhibitors
6
2023
68
1.250
Why?
Endometrial Neoplasms
10
2019
141
1.100
Why?
Antineoplastic Combined Chemotherapy Protocols
9
2020
1355
1.060
Why?
Drug Resistance, Neoplasm
15
2023
636
1.020
Why?
Genital Neoplasms, Female
6
2020
70
0.970
Why?
Uterine Cervical Neoplasms
8
2017
216
0.960
Why?
Peritoneal Neoplasms
6
2022
54
0.950
Why?
Antineoplastic Agents
10
2023
1879
0.800
Why?
Hysterectomy
4
2018
106
0.780
Why?
TNF-Related Apoptosis-Inducing Ligand
5
2017
40
0.690
Why?
Biomarkers, Tumor
8
2019
1040
0.670
Why?
Cystadenocarcinoma, Serous
5
2022
44
0.660
Why?
Gelatin
2
2016
36
0.640
Why?
Neoplasms, Glandular and Epithelial
3
2015
34
0.610
Why?
Models, Economic
1
2018
48
0.600
Why?
Thrombin
2
2016
139
0.600
Why?
Hyperthermia, Induced
1
2018
65
0.590
Why?
Female
79
2024
59507
0.540
Why?
Homeodomain Proteins
3
2012
463
0.540
Why?
Pelvic Infection
1
2016
4
0.530
Why?
Tissue Adhesives
1
2016
16
0.530
Why?
Fallopian Tube Neoplasms
5
2019
14
0.510
Why?
Cost-Benefit Analysis
1
2018
544
0.500
Why?
Neoplastic Cells, Circulating
2
2017
59
0.500
Why?
Cell Line, Tumor
18
2023
2710
0.490
Why?
Neoplasm Recurrence, Local
6
2019
858
0.490
Why?
Women
1
2015
51
0.470
Why?
Sirolimus
2
2016
181
0.470
Why?
Health Knowledge, Attitudes, Practice
2
2015
1183
0.410
Why?
Middle Aged
46
2020
26737
0.410
Why?
Vagina
5
2016
146
0.400
Why?
Antibodies, Neoplasm
1
2012
30
0.400
Why?
Cisplatin
2
2015
262
0.390
Why?
Humans
83
2024
114686
0.390
Why?
Neoadjuvant Therapy
4
2020
304
0.350
Why?
Aged
34
2020
19074
0.350
Why?
Neoplasm Staging
14
2019
1167
0.350
Why?
Claudin-4
3
2022
9
0.350
Why?
Robotic Surgical Procedures
3
2016
85
0.340
Why?
Uterine Neoplasms
4
2019
73
0.340
Why?
Aged, 80 and over
17
2020
6347
0.340
Why?
Apoptosis
8
2019
2363
0.330
Why?
Pelvic Exenteration
1
2009
11
0.330
Why?
Health Personnel
1
2015
574
0.330
Why?
Leiomyosarcoma
3
2020
26
0.330
Why?
Cytoreduction Surgical Procedures
2
2020
38
0.330
Why?
Pyrimidines
3
2019
376
0.330
Why?
Paclitaxel
3
2019
190
0.330
Why?
Phthalazines
2
2019
38
0.320
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
3
2017
26
0.320
Why?
Clinical Competence
1
2015
893
0.310
Why?
Chemotherapy, Adjuvant
2
2020
332
0.310
Why?
Carcinoma, Endometrioid
3
2019
46
0.300
Why?
Postoperative Complications
6
2020
2128
0.300
Why?
Caffeine
1
2008
57
0.300
Why?
Carbazoles
1
2008
78
0.300
Why?
Azepines
2
2019
75
0.300
Why?
Papanicolaou Test
2
2004
39
0.280
Why?
Vaginal Smears
2
2004
50
0.280
Why?
Piperazines
2
2019
309
0.280
Why?
Adult
29
2020
30550
0.280
Why?
Protein Kinase C
1
2008
273
0.270
Why?
Hemostasis, Surgical
2
2016
19
0.250
Why?
Adenocarcinoma
4
2015
795
0.250
Why?
Laparotomy
2
2015
103
0.240
Why?
Urban Health
1
2004
73
0.240
Why?
Gene Expression Regulation, Neoplastic
6
2020
1141
0.230
Why?
Disease-Free Survival
7
2017
620
0.230
Why?
Fallopian Tubes
1
2024
29
0.220
Why?
Pyrazoles
2
2020
362
0.220
Why?
Genetic Therapy
2
2014
257
0.220
Why?
Uterine Cervical Dysplasia
2
2003
42
0.200
Why?
Adenocarcinoma, Clear Cell
2
2021
14
0.200
Why?
Leiomyoma
2
2019
44
0.200
Why?
Healthcare Disparities
2
2018
480
0.200
Why?
Prognosis
8
2020
3329
0.190
Why?
Treatment Outcome
11
2020
9088
0.190
Why?
Piperidines
2
2019
160
0.190
Why?
Hospitals, Public
1
2001
22
0.190
Why?
BRCA2 Protein
3
2019
41
0.180
Why?
Mutation
5
2019
3346
0.180
Why?
Neoplasms
4
2017
2097
0.180
Why?
Hospitals, University
1
2001
172
0.180
Why?
Vulvar Neoplasms
1
2020
10
0.180
Why?
Cervix Uteri
3
2011
45
0.180
Why?
Epoxy Compounds
1
2020
31
0.170
Why?
Cell Movement
2
2016
869
0.170
Why?
Carnitine O-Palmitoyltransferase
1
2020
43
0.170
Why?
Enoxaparin
1
2020
52
0.170
Why?
Rad51 Recombinase
1
2019
14
0.170
Why?
Up-Regulation
2
2020
808
0.170
Why?
Receptors, Adiponectin
1
2019
15
0.170
Why?
Vaccines, Conjugate
1
2019
59
0.160
Why?
Pyridones
1
2020
123
0.160
Why?
Histocompatibility Antigens
1
2019
98
0.160
Why?
Poly(ADP-ribose) Polymerases
1
2019
88
0.160
Why?
Patient Acceptance of Health Care
1
2004
681
0.160
Why?
Sequence Analysis, RNA
2
2019
385
0.160
Why?
Interleukin-12
2
2014
110
0.160
Why?
Sarcoma
1
2020
137
0.160
Why?
Breast Neoplasms
4
2019
1862
0.160
Why?
Histone-Lysine N-Methyltransferase
1
2019
96
0.150
Why?
Lymph Node Excision
2
2020
139
0.150
Why?
Cancer Vaccines
1
2019
137
0.150
Why?
Ovariectomy
2
2015
116
0.150
Why?
Adjuvants, Immunologic
1
2019
206
0.150
Why?
Cost Savings
1
2018
74
0.150
Why?
Oncologists
1
2018
31
0.150
Why?
Pregnancy Complications, Infectious
1
2002
288
0.150
Why?
Cell Growth Processes
2
2008
51
0.150
Why?
Dose-Response Relationship, Drug
4
2008
1842
0.150
Why?
Tumor Microenvironment
1
2020
430
0.150
Why?
Neoplasm Grading
4
2019
242
0.140
Why?
Aurora Kinase A
1
2017
51
0.140
Why?
Survival Rate
5
2020
1644
0.140
Why?
Antineoplastic Agents, Phytogenic
1
2019
181
0.140
Why?
Leukocyte Common Antigens
1
2017
75
0.140
Why?
Risk Factors
6
2016
8632
0.140
Why?
beta Catenin
1
2019
219
0.140
Why?
Fatty Acids
1
2020
381
0.140
Why?
Anion Transport Proteins
1
2017
8
0.140
Why?
Salpingectomy
2
2015
13
0.140
Why?
Sexual Dysfunctions, Psychological
1
2017
31
0.140
Why?
Gestational Trophoblastic Disease
1
2016
5
0.140
Why?
Venous Thromboembolism
1
2020
231
0.140
Why?
Keratins
1
2017
176
0.140
Why?
Curettage
1
2016
9
0.140
Why?
Minority Groups
1
2018
227
0.140
Why?
Megestrol Acetate
1
2016
2
0.130
Why?
Carcinoma, Neuroendocrine
1
2016
29
0.130
Why?
Sexual Dysfunction, Physiological
1
2017
60
0.130
Why?
Gene Expression Profiling
2
2019
1518
0.130
Why?
Animals
12
2020
31706
0.130
Why?
Neoplasms, Squamous Cell
1
1996
4
0.130
Why?
Colony Count, Microbial
1
2016
111
0.130
Why?
Standard of Care
1
2016
62
0.130
Why?
Anticoagulants
1
2020
550
0.130
Why?
Medroxyprogesterone Acetate
1
2015
28
0.130
Why?
Gynecology
1
2018
163
0.130
Why?
Adenoviridae
1
1996
184
0.130
Why?
Brachytherapy
1
2016
103
0.130
Why?
Molecular Targeted Therapy
1
2018
347
0.130
Why?
Keratin-5
1
2015
46
0.120
Why?
Tretinoin
1
1996
122
0.120
Why?
Chemoradiotherapy
1
2016
188
0.120
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2017
923
0.120
Why?
Tamoxifen
1
2016
191
0.120
Why?
Combined Modality Therapy
4
2020
1121
0.120
Why?
Immunohistochemistry
3
2016
1629
0.120
Why?
Antineoplastic Agents, Hormonal
1
2015
138
0.120
Why?
Immunotherapy
1
2018
474
0.120
Why?
Surgeons
1
2018
239
0.120
Why?
CA-125 Antigen
2
2008
12
0.120
Why?
Abdominal Abscess
1
2014
25
0.120
Why?
Young Adult
5
2020
10469
0.120
Why?
Lipid Metabolism
1
2017
444
0.120
Why?
Reoperation
1
2016
514
0.110
Why?
Mice, SCID
2
2012
314
0.110
Why?
Cytokines
1
2002
1841
0.110
Why?
Kaplan-Meier Estimate
4
2020
811
0.110
Why?
Glycoproteins
1
2015
304
0.110
Why?
Interpersonal Relations
1
2017
341
0.110
Why?
Endometrium
1
2014
60
0.110
Why?
Quality of Health Care
1
2018
573
0.110
Why?
Mice
8
2020
14869
0.110
Why?
Proto-Oncogene Proteins c-akt
2
2016
398
0.110
Why?
Models, Biological
3
2019
1621
0.110
Why?
Transforming Growth Factor beta
1
1996
448
0.110
Why?
Antigens, CD
1
2015
442
0.110
Why?
Pelvic Neoplasms
1
2013
18
0.110
Why?
Plasmids
1
2014
343
0.110
Why?
Genes, Tumor Suppressor
3
1998
77
0.110
Why?
Escherichia coli
1
2016
720
0.100
Why?
RNA, Messenger
2
2012
2553
0.100
Why?
Neoplastic Stem Cells
1
2015
329
0.100
Why?
Antibody Specificity
1
2012
176
0.100
Why?
Cell Division
2
2008
758
0.100
Why?
RNA, Small Interfering
3
2020
535
0.100
Why?
Transplantation, Heterologous
1
2012
181
0.100
Why?
Endocrine Gland Neoplasms
1
2011
1
0.100
Why?
Drug Synergism
2
2011
316
0.090
Why?
Cyclin D1
1
2011
61
0.090
Why?
MicroRNAs
1
2017
600
0.090
Why?
Proteasome Inhibitors
1
2011
40
0.090
Why?
Adenocarcinoma, Mucinous
1
2011
60
0.090
Why?
Cell Proliferation
4
2019
2187
0.090
Why?
DNA
1
2017
1352
0.090
Why?
Peptides
1
2015
848
0.090
Why?
Transfection
2
2007
866
0.090
Why?
Cadherins
1
2011
175
0.090
Why?
Inflammation
1
2020
2480
0.090
Why?
Neoplasm Invasiveness
3
2016
442
0.090
Why?
Adolescent
5
2020
17844
0.080
Why?
Lymphoma
1
2011
177
0.080
Why?
Age Factors
5
2016
2894
0.080
Why?
Skin Transplantation
1
2009
57
0.080
Why?
Anastomosis, Surgical
1
2009
136
0.080
Why?
Cell Survival
3
2017
1021
0.080
Why?
Adaptor Proteins, Signal Transducing
1
2011
367
0.080
Why?
Papillomaviridae
2
2002
101
0.080
Why?
TOR Serine-Threonine Kinases
1
2011
358
0.080
Why?
Urokinase-Type Plasminogen Activator
1
2008
28
0.080
Why?
G2 Phase
1
2008
31
0.080
Why?
Case-Control Studies
4
2019
3003
0.080
Why?
Rectum
1
2009
153
0.080
Why?
Radiation-Protective Agents
1
2008
26
0.070
Why?
Models, Statistical
1
2011
599
0.070
Why?
Heterografts
2
2019
117
0.070
Why?
Xenograft Model Antitumor Assays
2
2020
698
0.070
Why?
Genes, BRCA1
2
1998
31
0.070
Why?
Class I Phosphatidylinositol 3-Kinases
2
2019
76
0.070
Why?
Microsatellite Instability
2
2019
32
0.070
Why?
Urinary Bladder
1
2009
162
0.070
Why?
Retrospective Studies
6
2020
12550
0.070
Why?
Cell Culture Techniques
2
2020
343
0.070
Why?
Tumor Suppressor Protein p53
3
2019
445
0.070
Why?
Cysteine
1
2008
171
0.070
Why?
Length of Stay
3
2015
962
0.070
Why?
Double-Blind Method
3
2019
1660
0.070
Why?
Gynecologic Surgical Procedures
2
2020
44
0.070
Why?
PTEN Phosphohydrolase
2
2019
140
0.070
Why?
Follow-Up Studies
4
2020
4411
0.070
Why?
Signal Transduction
4
2012
4513
0.070
Why?
Proportional Hazards Models
3
2020
1075
0.070
Why?
United States
5
2022
12183
0.070
Why?
Models, Animal
1
2008
344
0.070
Why?
Adenosarcoma
2
2005
2
0.070
Why?
Indazoles
2
2019
58
0.060
Why?
Cell Cycle
1
2008
542
0.060
Why?
Ovary
1
2007
191
0.060
Why?
Disease Progression
3
2019
2380
0.060
Why?
Colposcopy
2
2003
15
0.060
Why?
Intestinal Neoplasms
1
2005
24
0.060
Why?
Neoplasm Proteins
3
1998
385
0.060
Why?
Sexual Behavior
1
2009
440
0.060
Why?
Cell Count
2
2015
303
0.060
Why?
Germ-Line Mutation
2
1996
130
0.060
Why?
Ultraviolet Rays
1
2008
363
0.060
Why?
Chicago
1
2004
45
0.060
Why?
Tumor Cells, Cultured
2
1996
849
0.060
Why?
Transcription Factors
4
2011
1528
0.060
Why?
Peptide Fragments
1
2008
666
0.060
Why?
Antioxidants
1
2008
530
0.060
Why?
Blood Loss, Surgical
2
2015
84
0.060
Why?
Survival Analysis
4
2020
1211
0.050
Why?
Polymerase Chain Reaction
3
2002
993
0.050
Why?
Activating Transcription Factor 6
1
2023
16
0.050
Why?
Receptors, Estrogen
2
2015
372
0.050
Why?
Neoplasm Metastasis
2
2015
523
0.050
Why?
Transcription Factor AP-1
1
2023
80
0.050
Why?
Women's Health
1
2004
271
0.050
Why?
X-ray Repair Cross Complementing Protein 1
1
2022
14
0.050
Why?
Risk Assessment
3
2016
2968
0.050
Why?
Gardnerella vaginalis
1
2002
2
0.050
Why?
Pregnancy
3
2016
5518
0.050
Why?
Trichomonas vaginalis
1
2002
7
0.050
Why?
Phosphatidylinositol 3-Kinases
2
2016
329
0.050
Why?
Vaginal Neoplasms
1
2001
11
0.050
Why?
Gene Expression
1
2007
1421
0.050
Why?
Yeasts
1
2002
49
0.050
Why?
Vaginal Diseases
1
2001
17
0.050
Why?
Databases, Factual
2
2016
1125
0.050
Why?
Epithelial Cells
1
2007
951
0.050
Why?
Endometriosis
1
2001
40
0.050
Why?
DNA, Neoplasm
2
1998
157
0.050
Why?
Prospective Studies
4
2016
6220
0.050
Why?
Vulvectomy
1
2020
2
0.040
Why?
DNA Primers
1
2002
510
0.040
Why?
Histiocytoma, Malignant Fibrous
1
2020
4
0.040
Why?
Dermatofibrosarcoma
1
2020
9
0.040
Why?
Alleles
3
2017
789
0.040
Why?
Hospitals, Urban
1
2001
127
0.040
Why?
DNA Repair
1
2022
184
0.040
Why?
Clinical Trials, Phase I as Topic
1
2020
45
0.040
Why?
Medically Uninsured
1
2001
121
0.040
Why?
Liposarcoma
1
2020
26
0.040
Why?
Anoikis
1
2020
31
0.040
Why?
Diagnosis, Differential
2
2019
1342
0.040
Why?
Hemocyanins
1
2019
55
0.040
Why?
Interleukin-10
1
2002
299
0.040
Why?
Logistic Models
1
2004
1841
0.040
Why?
Rhabdomyosarcoma
1
2020
54
0.040
Why?
DNA Damage
1
2022
351
0.040
Why?
Chitinase-3-Like Protein 1
1
2019
17
0.040
Why?
Enzyme-Linked Immunosorbent Assay
1
2002
797
0.040
Why?
SEER Program
1
2020
196
0.040
Why?
Lymphatic Metastasis
1
2020
275
0.040
Why?
Radiotherapy
1
2020
176
0.040
Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2019
25
0.040
Why?
Intramolecular Oxidoreductases
1
2019
57
0.040
Why?
Poly-ADP-Ribose Binding Proteins
1
2019
31
0.040
Why?
DNA Polymerase II
1
2019
37
0.040
Why?
Cell Cycle Checkpoints
1
2019
84
0.040
Why?
Gene Knockdown Techniques
1
2020
299
0.040
Why?
Chromosomes, Human, Pair 7
1
1998
15
0.040
Why?
Mechanistic Target of Rapamycin Complex 1
1
2019
96
0.040
Why?
Cytoskeletal Proteins
1
2019
145
0.040
Why?
Mitosis
1
2019
164
0.040
Why?
Microtubule-Associated Proteins
1
2019
174
0.040
Why?
AMP-Activated Protein Kinases
1
2019
172
0.040
Why?
Europe
1
2019
334
0.040
Why?
Interleukin-6
1
2002
676
0.040
Why?
Wnt Signaling Pathway
1
2019
146
0.040
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
1998
30
0.040
Why?
Image Cytometry
1
2017
5
0.040
Why?
Interleukin-1
1
2002
966
0.040
Why?
Chromosomes, Human, Pair 14
1
1997
16
0.040
Why?
Socioeconomic Factors
1
2001
1078
0.030
Why?
Indoles
1
2019
304
0.030
Why?
Oxidation-Reduction
1
2020
923
0.030
Why?
Cell Differentiation
2
2011
1701
0.030
Why?
Ganciclovir
1
1996
49
0.030
Why?
Chromosome Deletion
1
1997
95
0.030
Why?
Time Factors
2
2019
6115
0.030
Why?
Hospitals, Private
1
2016
11
0.030
Why?
Mass Spectrometry
1
2019
633
0.030
Why?
Health Facility Size
1
2016
12
0.030
Why?
RNA-Binding Proteins
1
2019
345
0.030
Why?
Chorionic Gonadotropin
1
2016
78
0.030
Why?
Cell Separation
1
2017
291
0.030
Why?
AC133 Antigen
1
2015
19
0.030
Why?
Ifosfamide
1
1996
32
0.030
Why?
Marriage
1
2017
106
0.030
Why?
Cell Line, Transformed
1
1996
133
0.030
Why?
Tissue Array Analysis
1
2015
48
0.030
Why?
Hospital Charges
1
1996
39
0.030
Why?
Hospitals, Teaching
1
2016
103
0.030
Why?
Antigens, Neoplasm
1
2017
222
0.030
Why?
Tumor Burden
1
2016
259
0.030
Why?
Caspase 3
1
2016
235
0.030
Why?
Cystadenocarcinoma, Papillary
1
1995
5
0.030
Why?
Cell Cycle Proteins
1
2019
551
0.030
Why?
Carboplatin
1
1996
135
0.030
Why?
Disease Management
1
2019
560
0.030
Why?
DNA Mismatch Repair
1
2015
37
0.030
Why?
Ataxia Telangiectasia Mutated Proteins
1
2015
63
0.030
Why?
Ileus
1
2015
10
0.030
Why?
Genes, p53
1
1995
61
0.030
Why?
Income
1
2016
167
0.030
Why?
Elective Surgical Procedures
1
2016
151
0.030
Why?
Urinary Retention
1
2015
19
0.030
Why?
Sensitivity and Specificity
1
2019
1692
0.030
Why?
Histones
1
2019
535
0.030
Why?
Female Urogenital Diseases
1
2014
5
0.030
Why?
RNA Interference
1
2016
433
0.030
Why?
Taxoids
1
2015
93
0.030
Why?
Morbidity
1
2015
280
0.030
Why?
Intraoperative Complications
1
2015
122
0.030
Why?
Multivariate Analysis
2
1996
1430
0.030
Why?
Receptors, Androgen
1
2015
131
0.030
Why?
Bevacizumab
1
2015
115
0.030
Why?
Reference Values
1
1996
743
0.030
Why?
Drug Administration Schedule
1
2016
718
0.030
Why?
Point Mutation
1
1995
216
0.030
Why?
Blood Volume
1
2014
59
0.030
Why?
Bleomycin
1
1996
228
0.030
Why?
Infusions, Parenteral
1
2014
36
0.030
Why?
Polyethyleneimine
1
2014
18
0.030
Why?
Pelvis
1
2015
90
0.030
Why?
Deoxycytidine
1
2015
138
0.030
Why?
Insurance, Health
1
2016
244
0.030
Why?
DNA, Viral
1
1996
350
0.030
Why?
Hemostatics
1
2014
47
0.030
Why?
Tumor Suppressor Proteins
1
2016
282
0.030
Why?
Drainage
1
2014
151
0.030
Why?
Receptors, Progesterone
1
2015
319
0.030
Why?
Biomarkers
1
2024
3408
0.030
Why?
Urban Population
1
2016
397
0.030
Why?
Anemia
1
2015
143
0.030
Why?
Referral and Consultation
1
2018
635
0.030
Why?
Lipids
1
2017
580
0.030
Why?
Preoperative Care
1
2015
319
0.030
Why?
Patient Readmission
1
2018
610
0.030
Why?
Thrombocytopenia
1
2015
177
0.030
Why?
Gene Transfer Techniques
1
2014
147
0.030
Why?
Membrane Proteins
1
2019
1019
0.030
Why?
Ultrasonography
1
2016
634
0.030
Why?
Polymorphism, Single-Stranded Conformational
3
1998
25
0.030
Why?
Rural Population
1
2016
446
0.030
Why?
Linear Models
1
1994
768
0.030
Why?
Cholesterol
1
2014
367
0.030
Why?
Protein Kinase Inhibitors
1
2017
785
0.020
Why?
Zinc Finger E-box-Binding Homeobox 1
1
2011
23
0.020
Why?
Analysis of Variance
1
1994
1226
0.020
Why?
Perioperative Period
1
2011
49
0.020
Why?
Comorbidity
1
2016
1448
0.020
Why?
Tomography, X-Ray Computed
2
2014
2286
0.020
Why?
Mutant Proteins
1
2011
95
0.020
Why?
Risk Reduction Behavior
1
2013
201
0.020
Why?
DNA Fragmentation
1
2011
47
0.020
Why?
Fas Ligand Protein
1
2011
57
0.020
Why?
Hyperplasia
1
2011
163
0.020
Why?
Neovascularization, Pathologic
1
2012
281
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2015
663
0.020
Why?
Neoplasm Transplantation
1
2011
228
0.020
Why?
Polymorphism, Single Nucleotide
1
2017
1880
0.020
Why?
Administration, Oral
1
2012
728
0.020
Why?
Epithelial-Mesenchymal Transition
1
2011
167
0.020
Why?
Pregnancy Complications
1
2014
429
0.020
Why?
Quality of Life
1
2020
2353
0.020
Why?
Polyethylene Glycols
1
2014
561
0.020
Why?
Regression Analysis
1
2011
944
0.020
Why?
Patient Discharge
1
2015
772
0.020
Why?
Receptors, Urokinase Plasminogen Activator
1
2008
10
0.020
Why?
Injections, Subcutaneous
1
2008
134
0.020
Why?
Blotting, Western
1
2011
1147
0.020
Why?
Enzyme Inhibitors
1
2011
750
0.020
Why?
Quality Improvement
1
2015
950
0.020
Why?
Sulfonamides
1
2011
445
0.020
Why?
Placebos
1
2008
197
0.020
Why?
Mice, Hairless
1
2008
74
0.020
Why?
Disease Models, Animal
1
2016
3535
0.020
Why?
Chromosome Mapping
2
1998
487
0.020
Why?
Cross-Sectional Studies
1
2017
4409
0.020
Why?
Molecular Sequence Data
3
1996
2785
0.020
Why?
Genetic Markers
2
1998
320
0.020
Why?
Receptors, Cell Surface
1
2008
355
0.020
Why?
Frameshift Mutation
2
1996
27
0.020
Why?
Cohort Studies
1
2015
4895
0.020
Why?
Gene Deletion
2
1998
356
0.020
Why?
Carcinosarcoma
1
2005
17
0.020
Why?
Anti-Bacterial Agents
1
2014
1481
0.020
Why?
Colorado
1
2014
4099
0.010
Why?
DNA Mutational Analysis
2
1996
372
0.010
Why?
Severity of Illness Index
1
2011
2539
0.010
Why?
Obesity
1
2016
2508
0.010
Why?
Base Sequence
2
1996
2114
0.010
Why?
Loss of Heterozygosity
1
1998
40
0.010
Why?
Microsatellite Repeats
1
1998
136
0.010
Why?
Actuarial Analysis
1
1996
21
0.010
Why?
Genes, Neoplasm
1
1995
20
0.010
Why?
BRCA1 Protein
1
1995
56
0.010
Why?
Sequence Analysis, DNA
1
1998
723
0.010
Why?
Age of Onset
1
1996
446
0.010
Why?
Introns
1
1995
227
0.010
Why?
Exons
1
1995
302
0.010
Why?
Male
1
2017
55596
0.010
Why?
Amino Acid Sequence
1
1995
1982
0.010
Why?
Behbakht's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)